Superior vena cava obstruction associated with Nephrogenic Systemic Fibrosis

Journal of Drugs in Dermatology

Volumn 13, Issue 5, 2014, Pages 615-618

  Holzem, Kassandra E ^a   Nardone, Beatrice ^a   Lomasney, Jon W ^a   Yazdan, Pedram ^a   Gerami, Pedram ^a   West, Dennis P ^a   Laumann, Anne E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CONTRAST MEDIUM; GADOLINIUM;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CONTRAST ENHANCEMENT; DENDRITIC CELL; DIALYSIS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MEDICAL HISTORY; NEPHROGENIC SYSTEMIC FIBROSIS; SKIN BIOPSY; SKIN MANIFESTATION; SUPERIOR CAVA VEIN OBSTRUCTION; CHRONIC KIDNEY FAILURE; COMPLICATION; FATALITY; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; PATHOPHYSIOLOGY; SUPERIOR VENA CAVA SYNDROME;

CONTRAST MEDIA; FATAL OUTCOME; FEMALE; GADOLINIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; SUPERIOR VENA CAVA SYNDROME;

EID: 84900527752     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Girardi M, Kay J, Elston DM, Leboit PE, Abu-Alfa A. Cowper SE. Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol. Dec. 2011;65(6):1095-1106e1097
2. Chen AY, Zirwas MJ. Heffernan MP. Nephrogenic systemic fibrosis: a review. J Drugs Dermatol. Jul. 2010;9(7):829-834.
3. Cowper SE, Su LD, Bhawan J, Robin HS, Le Boit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol. Oct. 2001;23(5):383-393.
4. Ting WW, Stone MS. Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol. Jul. 2003;139(7):903-906.
5. Gibson SE, Farver CE Prayson RA. Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med. Feb. 2006;130(2):209-212.
6. Sanyal S, Marckmann P Scherer S. Abraham JL. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis-an autopsy-based review. Nephrol Dial Transplant. Nov. 2011;26(11):3616-3626.
7. George SJ, Webb SM, Abraham JL, Cramer SP Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis. Br J Dermatol. Nov. 2010;163(5):1077-1081.
8. Swaminathan S, High WA, Ranville J, et al. Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int. Jun. 2008;73(12):1413-1418.
9. Koreishi AF Nazarian RM, Saenz AJ, et al. Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med. Dec. 2009;133(12):1943-1948.
10. Baslaim G, De Varennes B. Localized idiopathic fibrosing mediastinitis as a cause of superior vena cava syndrome: a case report. Can J Surg. Feb. 1998;41(1):68-71.
11. Turk HM, Camci C, Buyukberber S, et al. Superior vena cava syndrome caused by chemotherapy-induced fibrosis. J Chemother. Aug. 2002;14(4):417-419.
12. Goudevenos JA, Reid PG, Adams PC, Holden MP Williams DO. Pacemakerinduced superior vena cava syndrome: report of four cases and review of the literature. Pacing Clin Electrophysiol. Dec. 1989;12(12):1890-1895.